(Press-News.org) COLUMBUS, Ohio – New research has shown that a protein does something that scientists once thought impossible: It unfolds itself and refolds into a completely new shape.
This protein, called RfaH, activates genes that allow bacterial cells to launch a successful attack on their host, causing disease. The researchers determined that RfaH starts out in its alpha form, composed of two spiral shapes. Later, in its beta form, it resembles spokes on a wheel and is called a barrel.
When RfaH refolds, it acquires a new function – yet another finding that researchers would not have predicted.
"We showed that RfaH refolds, which is a big enough deal already. You would think this is impossible. That's what you're told in school," said Irina Artsimovitch, professor of microbiology at Ohio State University and a lead author of the study. "But in this case, it's even better than that because we show that when RfaH refolds, it acquires a new function. It can do something that it couldn't do before."
Though the process happens in seconds, Artsimovitch likened the refolding to "having a knitted sweater that you rip out and then knit into a sweater with a different pattern."
The research is published in the July 20, 2012, issue of the journal Cell.
The findings have significant implications for studies of gene expression control and protein structure. This remarkable ability to refold suggests that RfaH and similar proteins might be able to bind in ways and to other molecules that had never been considered. Scientists who engineer proteins might have an entirely new step to add to their models. And now that the first case of a complete alpha to beta structural change has been demonstrated, chances are good that researchers will find other proteins that can do the same thing.
In particular, these findings are reminiscent of prion proteins, infectious agents that cause fatal brain diseases in humans and mammals. Prions refold from a harmless alpha into contagious beta forms, which initiate a chain reaction leading to the formation of large prion aggregates, the causative agents of diseases that include Creutzfeldt-Jakob Disease and bovine spongiform encephalopathy in cattle, also known as "mad cow disease."
All proteins fold into their designated shape, determined by DNA sequence, and have one job in a cell. For instance, some proteins, including RfaH, turn on gene expression – and typically that's the end of the story.
At the time of this study, the scientific community considered RfaH a transcription factor – a molecule that binds to specific DNA sequences to control the movement of genetic information from DNA to messenger RNA. Messenger RNA, also known as mRNA, carries those protein-building instructions as the gene expression process continues.
Artsimovitch and colleagues recently determined that RfaH closes a critical gap in the enzyme RNA polymerase, allowing it to maintain its grip on DNA and start the activation of genes. RNA polymerase is responsible for setting gene expression in motion in all cells by wrapping itself around the double helix of DNA, using one strand to match nucleotides and make a copy of genetic material.
But the researchers observed that when RfaH binds to DNA and RNA polymerase, its two halves separate, with one remaining bound to the enzyme and another holding on with just a string of a few amino acids. And then it refolds into a completely different shape.
This new work shows that refolding allows RfaH to participate in translation, a completely different step in gene expression. During translation, a molecule called a ribosome binds to mRNA and uses its instructions to select amino acids and join them into chains, which then fold to compose proteins, the final products of gene expression.
"You have factors that work on transcription and factors that work on translation. They are typically not the same," Artsimovitch said.
Research had long ago established that RfaH was a transcription factor, and that this function is universally conserved – meaning it is present for this role in all living organisms and has been for generations.
But this new research shows that RfaH is even more effective as a translation factor – about 100 times more powerful than it is as a transcription factor, Artsimovitch said. RfaH has more power during translation because it recruits the ribosome molecule under circumstances when there isn't enough information in the mRNA for the ribosome to do its protein construction.
"Normally the ribosome binds to a specific sequence. If there is no sequence, it doesn't know where to bind. We think that the ribosome recognizes RfaH instead of this sequence and starts translation," Artsimovitch said. "This is what we're going to be studying now, because it is completely unprecedented.
"RfaH can interact with the ribosome once it refolds. It's a really smart way to do it. It's a tiny protein, yet it can bind to both the RNA polymerase and the ribosome at the same time and link them together."
Artsimovitch and colleagues actually proposed several years ago that RfaH refolds because its observed structure was so different from what they expected. However, RfaH sequence could be folded in silico – via computer simulation – into the "correct" shape.
Paul Rösch, a scientist at the Universität Bayreuth in Germany and a lead author on this paper, tested this idea using high-tech nuclear magnetic resonance imaging. His lab found that RfaH can indeed fold into two very different states. The two labs then collaborated as Artsimovitch set out to determine the functional significance of RfaH refolding.
Artsimovitch has been using Escherichia coli as a model system for these studies. In these cells, the RfaH protein is a virulence factor that gives bacteria their ability to infect and cause disease. Though that role is not emphasized in this research, it makes sense that this particular protein would have some special qualities, Artsimovitch explained.
Genes that control bacterial virulence are famous for being designed in a way that makes their translation very inefficient – hence, they need specialized proteins to help their expression. If RfaH didn't refold and enable translation, certain genes would not be expressed, and in the wild, these bacteria could not survive.
The researchers determined that the separation of the protein's domains, or sections, triggers the refolding because they could reproduce that event experimentally. But they haven't yet determined exactly what allows that dissociation to happen, and are designing models in which to further investigate the refolding process.
"There is actually a big question here: How does RfaH know where to begin binding to the message to recruit the ribosome? We can tell that the ribosome knows where to start, but how it knows, we have no idea," Artsimovitch said.
This work is supported by grants from the National Institutes of Health and DFG (German Research Foundation).
### Additional co-authors include Björn Burmann, Stefan Knauer and Kristian Schweimer of Universität Bayreuth in Germany; Anastasia Sevostyanova of Ohio State's Department of Microbiology; and Robert Landick and Rachel A. Mooney of the University of Wisconsin.
Contact: Irina Artsimovitch, (614) 292-6777; Artsimovitch.1@osu.edu
Written by Emily Caldwell, (614) 292-8310; Caldwell.151@osu.edu
Like a transformer? Protein unfolds and refolds for new function
2012-07-20
ELSE PRESS RELEASES FROM THIS DATE:
Immune drug helps patients with serious kidney disorder
2012-07-20
Highlights
Patients with a particular kidney immune disorder experienced remission when taking the immune drug rituximab, even when standard therapies had failed.
Rituximab was safe and well-tolerated by all patients in the study.
Each year, an estimated 70,000 people globally are diagnosed with the disorder, called idiopathic membranous nephropathy.
Washington, DC (July 19, 2012) — A drug commonly used to treat immune disorders such as lymphoma and arthritis also benefits patients with an immune disorder of the kidneys that can lead to kidney failure, according to ...
Study questions safety and effectiveness of common kidney disease drugs
2012-07-20
Highlights
Phosphate binders, drugs commonly prescribed to patients with chronic kidney disease, may not be as effective as previously thought.
Phosphate binders may have negative effects on cardiovascular health.
Additional studies are needed on the safety and effectiveness of these drugs.
Washington, DC (July 19, 2012) — Drugs commonly prescribed to patients with chronic kidney disease (CKD) may not be as strongly effective as once thought, and may cause unexpected harm to blood vessels, according to a study appearing in an upcoming issue of the Journal of ...
New technique reveals cross-talk between 2 essential cellular processes
2012-07-20
LA JOLLA, CA – Scientists at The Scripps Research Institute have simultaneously mapped two of the most important types of protein-modification in cells, revealing their extensive cooperation during an essential cellular process.
Phosphorylation, the attachment of a phosphate group to a protein, and proteolysis, the cleavage of a protein, had almost always been studied independently. The new research combines techniques for mapping these events across all proteins in a cell population to show how they work together to execute the cellular "auto-destruct program" known ...
Debate ends: Everyone was right
2012-07-20
KANSAS CITY, MO—Scientists at the Stowers Institute of Medical Research have developed an innovative method to count the number of fluorescent molecules in a cluster and then applied the novel approach to settle a debate rampant among cell biologists—namely, how DNA twists into a unique chromosomal structure called the centromere. Knowing this helps explain how cells navigate the hazards of division and avoid the disastrous consequences of ending up with the wrong number of chromosomes.
Centromeres, which sit at the cross point of the "X" used to represent duplicated ...
The Yin and Yang of stem cell quiescence and proliferation
2012-07-20
KANSAS CITY, MO—Not all adult stem cells are created equal. Some are busy regenerating worn out or damaged tissues, while their quieter brethren serve as a strategic back-up crew that only steps in when demand shoots up. Now, researchers at the Stowers Institute for Medical Research have identified an important molecular cue that keeps quiescent mouse hematopoietic (or blood-forming) stem cells from proliferating when their services are not needed.
Publishing in the July 20, 2012 issue of Cell, the team led by Stowers Investigator Linheng Li, Ph.D., report that Flamingo ...
Lack of insurance linked to advanced stage cervical cancer
2012-07-20
ATLANTA –July 19, 2012—A large national sample of women diagnosed with cervical cancer between 2000 and 2007 finds lack of insurance was second only to age as the strongest predictor of late stage at diagnosis, a gap the authors say is likely attributable to lack of screening.
The American Cancer Society estimates that 12,170 women will be diagnosed with cervical cancer and 4,220 women will die from the disease in 2012. Although incidence and mortality from cervical cancer have declined dramatically since the introduction of the Pap test, one in three cervical cancer ...
Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
2012-07-20
PHILADELPHIA — Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors. Clear genetic rationale for these trials, together with evidence that primary and metastatic lung tumors might be particularly susceptible to the drugs, is now reported in a preclinical study published in Cancer Discovery, a journal of the American Association for Cancer Research.
"Our data provide preclinical genetic validation for the ongoing clinical trials testing IDO inhibitors in cancer patients," ...
Team discovers how western corn rootworm resists crop rotation
2012-07-20
CHAMPAIGN, Ill. — A new study answers a question that has baffled researchers for more than 15 years: How does the western corn rootworm – an insect that thrives on corn but dies on soybeans – persist in fields that alternate between corn and soybeans? The answer, researchers say, has to do with enzyme production in the rootworm gut.
Their findings are described in a paper in Ecology and Evolution.
Crop rotation declined in the middle of the 20th century as the use of insecticides and fertilizers expanded in the U.S. Then in the 1950s and '60s, when some insecticides ...
NYU Langone Medical Center's tip sheet to the Alzheimer's Association International Conference
2012-07-20
NEW YORK, JULY 15, 2012 – Experts from the Comprehensive Center on Brain Aging at NYU Langone Medical Center will present new research at The 2012 Alzheimer's Association International Conference on Alzheimer's Disease to be held in Vancouver, British Columbia, Canada, July 14 – July 19.
From basic discovery to clinical applications, NYU Langone Medical Center has been at the forefront of the diagnosis and treatment of Alzheimer's disease since the 1970s. The Comprehensive Center on Brain Aging, founded upon the strengths of the Silberstein Alzheimer's Institute, is ...
Locating muscle proteins
2012-07-20
Muscle contraction and many other movement processes are controlled by the interplay between myosin and actin filaments. Two further proteins, tropomyosin and troponin, regulate how myosin binds to actin. While theoretical models have in fact described exactly how these muscle proteins interact, this interaction has never previously been observed in detail. Stefan Raunser and Elmar Behrmann from the Max Planck Institute of Molecular Physiology in Dortmund have now managed to image the actin-myosin-tropomyosin complex with an unprecedented accuracy of 0.8 nanometres, which ...